M-リボミック(4591) RIBOMIC Provides Update on the Status of Its Phase 2 Clinical Trial of RBM-007 (TOFU Study) in Subjects with Wet Age-Related Macular Degeneration
2020/03/24
ブックマーク
メモを書く
/
-
読み込み中…